These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37923694)

  • 1. In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine.
    Alizadeh M; Raj S; Shojadoost B; Matsuyama-Kato A; Boodhoo N; Abdelaziz K; Sharif S
    Vaccine; 2023 Nov; 41(48):7281-7289. PubMed ID: 37923694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of an inactivated influenza vaccine adjuvanted with Toll-like receptor ligands against transmission of H9N2 avian influenza virus in chickens.
    Raj S; Alizadeh M; Matsuyama-Kato A; Boodhoo N; Denis MS; Nagy É; Mubareka S; Karimi K; Behboudi S; Sharif S
    Vet Immunol Immunopathol; 2024 Feb; 268():110715. PubMed ID: 38219434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    BMC Res Notes; 2018 Jul; 11(1):428. PubMed ID: 29970157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced infection of avian influenza virus H9N2 with infectious laryngeotracheitis vaccination in chickens.
    Arafat N; Eladl AH; Marghani BH; Saif MA; El-Shafei RA
    Vet Microbiol; 2018 Jun; 219():8-16. PubMed ID: 29778208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
    Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
    Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
    Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
    Lone NA; Spackman E; Kapczynski D
    Vaccine; 2017 Jun; 35(26):3401-3408. PubMed ID: 28511853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic Lactobacilli Enhance Immunogenicity of an Inactivated H9N2 Influenza Virus Vaccine in Chickens.
    Alqazlan N; Astill J; Taha-Abdelaziz K; Nagy É; Bridle B; Sharif S
    Viral Immunol; 2021 Mar; 34(2):86-95. PubMed ID: 33236974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
    Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
    Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection.
    Park JK; Lee DH; Cho CH; Yuk SS; To EO; Kwon JH; Noh JY; Kim BY; Choi SW; Shim BS; Song MK; Lee JB; Park SY; Choi IS; Song CS
    Vet Microbiol; 2014 Mar; 169(3-4):211-7. PubMed ID: 24472228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2.
    Rahman MM; Uyangaa E; Han YW; Kim SB; Kim JH; Choi JY; Yoo DJ; Hong JT; Han SB; Kim B; Kim K; Eo SK
    Vet Microbiol; 2011 Dec; 154(1-2):140-51. PubMed ID: 21764226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
    Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
    Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.